Alle patienter havde tidligere fået mindst to proteasehæmmerbaserede, antiretrovirale behandlingsregimer, og på inklusionstidspunktet svigtede en proteasehæmmerbaseret behandlingsregime.
All patients had received at least two PI-based antiretroviral regimens and were failing a PI-based regimen at the time of study entry.